PP
ANAB icon

PDT Partners’s AnaptysBio ANAB Stock Holding History

PDT Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,595
Closed -$976K – 498
2026
Q1 		$976K Sell
17,595
-25,406
-59% -$1.37M 0.06% 346
2025
Q4 		$2.08M Hold
43,001
– – 0.14% 243
2025
Q3 		$1.32M Sell
43,001
-1,464
-3% -$33.6K 0.08% 316
2025
Q2 		$987K Sell
44,465
-64
-0.1% -$1.34K 0.06% 421
2025
Q1 		$828K Buy
+44,529
New +$743K 0.06% 423
2024
Q4 		– Sell
-7,554
Closed -$253K – 711
2024
Q3 		$253K Sell
7,554
-6,296
-45% -$215K 0.02% 628
2024
Q2 		$347K Sell
13,850
-2,439
-15% -$56.8K 0.03% 531
2024
Q1 		$367K Buy
+16,289
New +$386K 0.03% 504
2021
Q1 		– Sell
-31,775
Closed -$683K – 764
2020
Q4 		$683K Sell
31,775
-32,478
-51% -$789K 0.05% 396
2020
Q3 		$948K Sell
64,253
-200
-0.3% -$3.61K 0.06% 317
2020
Q2 		$1.44M Sell
64,453
-28,255
-30% -$517K 0.1% 239
2020
Q1 		$1.31M Sell
92,708
-2,263
-2% -$34.3K 0.1% 199
2019
Q4 		$1.54M Buy
+94,971
New +$2.25M 0.1% 218

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

PDT Partners's ANAB Position: Q2 2026 in Review

PDT Partners sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 17,595 shares — an estimated $976K sold.

PDT Partners first reported a position in ANAB in Q4 2019 and held it in 13 quarters. The position peaked at $2.08M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • PDT Partners reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • PDT Partners sold 17,595 AnaptysBio shares in Q2 2026, an estimated $976K.
  • PDT Partners first reported a position in AnaptysBio in Q4 2019 and held it in 13 quarters.
  • PDT Partners's AnaptysBio position peaked at $2.08M in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.